Skip to main content

Beneficial effects of hypotaurine supplementation in preparation and freezing media on human sperm cryo-capacitation and DNA quality

Abstract

Background

Although widely used, slow freezing considerably modifies the functions of human spermatozoa. Cryopreservation induces nuclear sperm alterations and cryo-capacitation, reducing the chances of pregnancy. Hypotaurine is naturally present in the male and female genital tracts and has capacitating, osmolytic and anti-oxidant properties. The analysis were performed on surplus semen of men with normal (n = 19) or abnormal (n = 14) sperm parameters. Spermatozoa were selected by density gradient centrifugation before slow freezing. For each sample, these steps were performed in parallel with (“H+” arm) or without (“H-” arm) hypotaurine supplementation. After thawing, we measured total and progressive mobility, vitality, acrosome integrity, markers of capacitation signaling pathway and nuclear quality. For the latter, we focused on sperm chromatin packaging, DNA fragmentation and the presence of vacuoles in the sperm nucleus.

Results

Post-thaw spermatozoa selected and frozen in the presence of hypotaurine had a higher vitality (+ 16.7%, p < 0.001), progressive and total motility (+ 39.9% and +  21.6% respectively, p < 0.005) than spermatozoa from the control “H-” arm. Hypotaurine also reduced the non-specific phosphorylation of the capacitation protein markers P110 and P80 (p < 0.01), indicating a decrease in cryo-capacitation. Hypotaurine supplementation reduced chromatin decondensation, measured by chromomycin A3 (− 16.1%, p < 0.05), DNA fragmentation (− 18.7%, p < 0.05) and nuclear vacuolization (− 20.8%, p < 0.05).

Conclusion

Our study is the first to demonstrate beneficial effects of hypotaurine supplementation in preparation and freezing procedures on human spermatozoa sperm fertilization capacity and nucleus quality. Hypotaurine supplementation limited cryo-capacitation, increased the proportion of live and progressively motile spermatozoa and reduces the percentage of spermatozoa showing chromatin decondensation, DNA fragmentation and nuclear vacuolation.

Trial registration

Clinical Trial, NCT04011813. Registered 19 May 2019 - Retrospectively registered.

Résumé

Contexte

Bien que largement utilisée, la congélation lente modifie considérablement les fonctions des spermatozoïdes humains. La cryoconservation induit des altérations nucléaires du sperme et une cryocapacitation, réduisant les chances de grossesse. L’hypotaurine est. naturellement présente dans les voies génitales masculines et féminines et possède des propriétés capacitantes, osmotiques et anti-oxydantes. Les mesures ont été réalisées sur le reliquat de sperme d’hommes avec des paramètres spermatiques normaux (n = 19) ou anormaux (n = 14). Les spermatozoïdes ont été sélectionnés par centrifugation sur gradient de densité (test de migration survie) avant congélation lente. Pour chaque prélèvement, ces étapes ont été réalisées en parallèle avec des milieux supplémentés en hypotaurine (bras « H+ ») ou sans hypotaurine (bras « H- »). Après décongélation, nous avons mesuré la mobilité totale et progressive, la vitalité, l’intégrité de l’acrosome, des marqueurs de la voie de signalisation de la capacitation et la qualité nucléaire. Pour cette dernière, nous nous sommes concentrés sur la condensation de la chromatine, la fragmentation de l’ADN et la présence de vacuoles dans le noyau du sperme.

Résultats

Post-décongélation, les spermatozoïdes sélectionnés et congelés en présence d’hypotaurine avaient une vitalité plus élevée (+ 16,7%, p < 0,001), une motilité progressive et totale (+ 39,9% et + 21,6% respectivement, p < 0,005) que les spermatozoïdes du bras « H- » sans suplémentation. L’hypotaurine a également réduit la phosphorylation non spécifique des marqueurs protéiques de capacitation P110 et P80 (p < 0,01), indiquant une diminution de la cryocapacitation. La supplémentation en hypotaurine a réduit la décondensation de la chromatine, mesurée par la chromomycine A3 (− 16,1%, p < 0,05), la fragmentation de l’ADN (− 18,7%, p < 0,05) et la vacuolisation nucléaire (− 20,8%, p < 0,05).

Conclusion

Notre étude est. la première à démontrer les effets bénéfiques de la supplémentation en hypotaurine dans les milieux de préparation et de congélation sur la capacité de fécondation des spermatozoïdes humains et leur qualité nucléaire. La supplémentation en hypotaurine a limité la cryocapacitation, augmenté la proportion de spermatozoïdes vivants et progressivement mobiles et réduit le pourcentage de spermatozoïdes présentant une décondensation de la chromatine, une fragmentation de l’ADN et une vacuolisation nucléaire.

Enregistrement de l’essai

essai clinique, NCT04011813. Enregistré le 19 mai 2019 - Enregistré rétrospectivement.

Background

Despite advances in cryobiology, slow freezing remains the standard method of cryopreservation of human spermatozoa [1,2,3]. Nevertheless, this method considerably affects sperm integrity, decreasing vitality and motility, and inducing both structural and functional changes, resulting in decreased sperm fertilizing capacity [4,5,6,7]. Freeze-thaw cycles also increase the production of reactive oxygen species (ROS) and reduce the amount and activity of antioxidant (AO) systems, leading to oxidative stress (OS, for reviews see [8,9,10]). The effects of the latter are well known: disruption of plasma, acrosomal and mitochondrial membranes; impaired motility and fertilisation capacity; and, finally, sperm death, especially by apoptosis [1, 10,11,12]. OS is also the main source of DNA damage, resulting in base oxidation, DNA fragmentation and chromatin packaging disorders [13, 14]. Previous studies have reported, after thawing a higher percentage of spermatozoa without acrosomes or with an altered acrosomal membrane, and an increased proportion of spermatozoa with cryo-capacitation characteristics. These sperm alterations are associated with premature capacitation or acrosome reaction or both, with low fertilization capacity and limited survival time [6, 15,16,17].

To reduce the deleterious effects of the freeze-thaw cycle, two main strategies have been reported. The first is the selection of high-quality spermatozoa, notably by density gradient centrifugation (DGC) or swim up [5, 18]. This technique removes the most immature germ cells, immune or epithelial cells, and dead or abnormal spermatozoa, thereby helping to reduce sources of ROS. However, the removal of seminal fluid deprives sperm cells of their natural AO protection [19], which has a detrimental effect, especially on abnormal semen, as has been reported recently [20]. The second strategy is more common and consists of providing AO to protect spermatozoa [21,22,23,24,25,26,27]. Few studies have shown the beneficial effect of combining the two strategies [28, 29]. In one such study [28], semen samples from patients with oligo-astheno-teratozoospermia (OAT) were selected by DGC and supplemented with hypotaurine, which was also added to the washing and cryopreservation media. We showed beneficial effects, including a decrease in the proportion of spermatozoa with phosphatidylserine externalization, an increase in spermatozoa mitochondrial potential and a decrease in DNA fragmentation.

In order to substantiate the beneficial effects of such a strategy, the objective of this study was to investigate further the effects of hypotaurine supplementation on a wide range of sperm parameters, with particular emphasis on sperm fertilizing ability and DNA quality. To this end, we simultaneously evaluated: (i) conventional sperm parameters; (ii) fertilization capacity by measuring acrosome integrity, the level of cryocapacitated spermatozoa after thawing and the ability of sperm cells to capacitate in vitro; (iii) sperm nuclear alterations such as chromatin decondensation, DNA fragmentation and the presence of vacuoles in the sperm heads (i.e. nuclear vacuolation).

Materials and methods

Experimental design, ethical statement and patient characteristics

The experimental design is shown in Fig. 1. Samples were obtained from 33 men undergoing routine semen analysis at the Center for Reproductive Medicine. Semen samples were collected and conventional analyses were performed in accordance with World Health Organization (WHO) 2010 guidelines [30]. Each sperm sample was split in two and processed in parallel in two ways: an “H” control arm: DGC before freezing without hypotaurine supplementation and an “H+” arm: DGC before freezing with a 50 mM hypotaurine supplementation in DGC, washing and freezing media. Spermatozoa were frozen in high-security straws (CBS™, Crybiosystem, L’Aigle, France) in the presence of Cryosperm® freezing medium (Origio, Malov, Denmark) and stored at − 196 °C in liquid nitrogen until use. After thawing, the analyses were performed in parallel for the two conditions. These included: (i) standard semen parameter evaluation, (ii) sperm fertilizing capacity, and (iii) sperm nuclear quality. Thirty-three patients with a mean age of 33.5 ± 0.8 years (Table 1) were included in the study. The mean body mass index (BMI) was 26.2 ± 0.8 (Table 1). Semen parameters are presented in Tables 1, 19 samples were normozoospermic and 14 had abnormal semen parameters including teratozoospermia, asthenozoospermia and high level of leukocytes.

Fig. 1
figure1

Experimental study design. Samples were obtained from 33 men undergoing routine semen analysis. Excess semen from each sample was split in two and processed in parallel in two ways: a control arm “H -”: sperm cells were processed by density gradient centrifugation (DGC) without hypotaurine supplementation, and an “H +” arm: spermatozoa were processed by 50 mM hypotaurine supplementation during DGC. Spermatozoa were washed and frozen in high-security straws in the presence of hypotaurine supplemented (H+) or non-hypotaurine supplemented (H-) media. After thawing, the different analyzes were carried out in parallel for both conditions: - (i) Analysis of standard semen parameters (n = 33): Sperm vitality,progressive and total motilities. - (ii) Measurements of fertilization capacity: Evaluation of (cryo-) capacitation terminal markers by measuring tyrosine phosphorylation of P110 and P80 (n = 15) and analysisof acrosome integrity after FITC- PSA labeling (n = 25), and - (iii) Measurements of nuclear quality markers: Chromatin condensation measured by chromomycin A3 (n = 28), DNA fragmentation by TUNEL assay (n = 18), and nuclear vacuolization observed by examination of motile sperm organelle morphology (MSOME, n = 19)

Table 1 Clinical characteristic and standard semen parameters

Chemicals

All chemicals were purchased from Sigma-Aldrich (St-Quentin-Fallavier, France) unless otherwise indicated.

Semen collection and preparation

Semen samples were collected by masturbation in sterile containers after a period of 2–7 days of sexual abstinence. Conventional semen analysis were performed in accordance with the WHO 2010 guidelines [30]. All sperm counts are the result of two independent readings. Leukocytes were detected using the LeucoScreen kit (FertiPro N.V., Beernem, Belgium). The proportion of viable spermatozoa (vitality) was estimated by assessing sperm membrane integrity by eosin-nigrosin staining using the Vital Screen Kit (FertiPro N.V.). Morphology was estimated according to Krüger’s stricter criteria [31]. Surplus semen was processed by a two-stage (90/45%), 750 g, 20 min, discontinuous density gradient centrifugation (DGC) at room temperature (RT) using a fresh gradient medium consisting of Puresperm® medium (Nidacon International, Molndal, Sweden) diluted with balanced Sperm Preparation® medium (Origio, Malov, Denmark). The high density fraction was then washed by centrifugation in Sperm Preparation® medium at 750 g, for 8 min at RT and the pellet was resuspended in the washing medium. Samples were mixed in a 1:1 ratio (v/v) with a cryoprotective medium (Cryosperm, Origio, Malov, Denmark) according to the supplier’s recommendations. Afterwards sperm samples were frozen in high security straws (Cryobiosystem®) in a NanoDigitcool® programmable freezer (Cryobiosystem®) and stored in a liquid nitrogen tank (CF250M, Cryodiffusion®, Lery, France) as previously described [28]. For the H+ arm, all media were supplemented with a final concentration of 50 mM of hypotaurine as previously described [28].

For thawing, the straws were placed at 37 °C for 3 min. After a multi-step addition of Sperm Preparation® medium, the cryoprotectant was removed by centrifugation (750 g, 5 min, RT). Finally, a second wash was performed with Sperm Preparation® medium (750 g, 5 min, RT) and the samples were dispatched for evaluation.

Fertilizing ability measurements

Western blot of the capacitation terminal markers

Sperm capacitation and cryo-capacitation were estimated by monitoring tyrosine phosphorylation (P-Tyr) of the P80 and P110 proteins by the western-blot procedure (n = 15), by using an anti-phosphotyrosine monoclonal antibody (clone 4G10; Upstate Biotechnology Inc., Lake Placid, NY). For all the samples, the P-Tyr of P80 and P110 were evaluated in spermatozoa directly after thawing, indicating basal phosphorylation of both markers due to cryo-capacitation, and after 3 h incubation under capacitating conditions (Sperm Preparation medium, 37 °C and 5% CO2) corresponding to effective capacitation. Incubations under capacitating conditions and immunoassays were performed as described in previous studies [32]. The same membranes were probed again using the same protocol with a mouse anti α-tubulin monoclonal antibody. P-Tyr profiles and tubulin signals were quantified and the P-Tyr signal was normalized to that of tubulin. For each condition, the ratio obtained after different incubation times was related to the ratio obtained before incubation.

Acrosomal integrity measurements

For the evaluation of acrosomal integrity, spermatozoa from 25 samples were fixed and permeabilized in methanol 98% after washing with Phosphate Buffer Saline (PBS) 1X. Sperm cells were incubated with a freshly prepared solution of P. sativum agglutinin conjugated to fluorescein isothiocyanate (FITC-PSA, 60 μg/ml final) in PBS 1X for 30 min at 4 °C in a humid chamber as indicated in prior studies [33]. After washing, the spermatozoa were observed in an epifluorescence microscope (× 400). Sperm cells with their acrosomal membranes showed marked fluorescence on the acrosomal region, while those that had lost their acrosomal membrane (AR for acrosome reacted) were either devoid of fluorescence or showed a fluorescence mark along the equatorial segment. A total of 200 spermatozoa per slide were counted blind twice for each condition.

Measurement of nuclear quality markers

Chromatin packaging measurements

Chromatin decondensation measurements were performed by using chromomycin A3 labelling (n = 28). Spermatozoa were fixed in methanol/glacial acetic acid (3:1) at 4 °C for 5 min, before being labelled with CMA3 solution (0.25 mg/ml of McIlvaine buffer, pH 7.0 and 10 mM of MgCl2) in a humid chamber. Bright yellow sperm heads are a sign of abnormally condensed chromatin. A total of 200 spermatozoa per slide were counted blind twice for each condition.

DNA fragmentation measurements

Sperm DNA fragmentation (n = 19) was measured by using the TUNEL detection Kit (Cell Death Kit detection POD®, Roche, France) as previously described [28]. After washing by centrifugation (500 g, 5 min, TA, PBS 1X), 1.106 spermatozoa were fixed in 4% (w/v) paraformaldehyde. After being washed in PBS 1X-BSA 1%, sperm samples were resuspended in a permeabilization solution containing 0.1% (v/v) Triton-X and 0.1% (w/v) sodium citrate for 3 min in ice. After washing (500 g, 5 min, RT), the labeling reaction was carried out by incubating for 1 h at 37 °C with the enzyme and the labeling solution. The cell suspension was then washed in 1% (v/v) PBS-BSA and counter-stained with propidium Iodide (PI, 2 mg/ml) to check the effectiveness of the permeabilization before flow cytometric (FCM) measurements.

Flow Cytometry measurements

Flow Cytometry measurements were performed on a minimum of 20,000 spermatozoa using a BD FACS Aria SORP cell sorter (BD Biosciences, Franklin Lakes, NJ) with an 85 μm nozzle. The FSC (forward-scattered light) and SSC (side-scattered light) were detected on a linear scale and used to gate cells. The fluorochromes were excited at a wavelength of 488 nm by an argon laser. Green (FITC) and red (PI) fluorescence were detected at FL1 by a 525 nm bandwidth filter and at FL3 by a 620 nm bandwidth filter. The fluorescence signals detected at FL1 and FL3 were recorded after logarithmic amplification and the percentage of marked cells was calculated by the flow cytometer software. Sperm gating was confirmed by microscopy after cell sorting.

Nuclear vacuolization analysis

Nuclear vacuolization was estimated for 19 samples by motile sperm organelle morphology examination (MSOME) in an inverted microscope (Leica AM 6000 micromanipulator, Nanterre, France) equipped with a Hoffman and Nomarski interferential contrast with a dry objective of × 6300. Sperm suspensions were observed in a microdrop of 5 μl PVP (Polyvinylpyrrolidone, Clinical Grade®, Origio, Malov, Denmark) in a sterile glass dish covered with mineral oil (Ovoil®, Vitrolife, Västra Frölunda, Sweden). The spermatozoa were classified into 2 groups: (i) those with a large head vacuole or 2 or more small vacuoles; (ii) a normal group of those without a vacuole or with one small nuclear vacuole. A total of 200 spermatozoa were counted twice blind for each condition.

Statistics

All statistical analyses were performed using STATA® software (version 13, StataCorp, College Station, Lakeway Drive, USA). Data are presented as mean ± standard error of the mean (SEM). For each paired comparison, the statistical difference was evaluated using paired parametric (Student’s t-test) or non-parametric (Wilcoxon test) tests. The assumption of normality was studied using Shapiro-Wilk’s test and the homoscedasticity was analyzed by the use of Pitman’s test. The results were expressed using effect-size (ES) values with 95% confidence interval (C.I.) [34]. Subgroups analyses of abnormal and normal samples were carried out for the parameters for which the sample number in the both groups was greater than or equal to 10, that is to say mobility, vitality, DNA compaction and acrosome integrity. The relationships between continuous parameters were evaluated by Pearson or Spearman correlation coefficients (noted rho coefficient) according to the statistical distribution and applying a Sidak’s type I error correction. Results were represented using a color-coded heatmap in order to illustrate the different correlations.

Results

Sperm vitality and motility improvement

Sperm vitality, total and progressive motility were significantly reduced after thawing compared with fresh sperm values (Table 1) for both H- (p < 0.0001 for all three parameters) and H+ (p< 0.0001 for vitality, p<0.01 and p < 0.05 for total and progressive motility respectively) arms (Table 2). These three parameters were significantly higher for the H+ condition than H- one (+ 16.6% p < 0.001 for vitality, + 39.8% and +  21.8% p < 0.005 for progressive and total motility, Table 2, all patients). Hypotaurine supplementation was particularly beneficial on abnormal sperm samples (+ 20.4%, ES = 0.40 [0.10; 0.74], + 32.3%, ES = 0.48 [0.05; 1.05]; 40.3%, ES = 0.54 [0.01; 1.13] for vitality and progressive and total motility respectively, Table 2).

Table 2 Effects of hypotaurine supplementation on standard semen parameters

Sperm cryo-capacitation limitation

After thawing, we observed lower levels of phosphorylation of P110 and P80 proteins for the H+ condition, indicating a lower level of cryo-capacitation than the H- one (p < 0.01 for both P110 and P80, Fig. 2A). After 3 h of incubation under capacitation conditions, the phosphorylation levels of P110 and P80 tended to be higher for the H+ condition compared to the H- one, although this was not statistically significant for either P110 (3.5 ± 1.0 for H- vs. 4.4 ± 1.0 a.u. for H+, p = 0.23 Fig. 2A) or for P80 (3.6 ± 0.9 for H- vs. 4.5 ± 1.0 a.u. for H+, p = 0.08). We did not measure a significant difference between the two conditions with respect to the percentage of spermatozoa with altered or absent acrosomes (65.1 ± 3.2 for H- vs. 64.4 ± 3.1% for H+, AR %, Fig. 2B). No significant effect was measured either for normal (60.0 ± 4.6 for H- vs. 60.6 ± 4.5% for H+ for) or for abnormal (71.7 ± 3.5 for H- vs. 69.3 ± 3.7% for H+) sperm samples.

Fig. 2
figure2

Effects of hypotaurine supplementation on sperm fertilization capacity after thawing. Numbers are averaged ± SEM for (A) P110 and P80 (arbitrary units: a.u.) and percent ± SEM for (B) acrosome integrity (%). “H -”: sperm cells were processed by density gradient centrifugation (DGC), washed and frozen without hypotaurine supplementation. “H +”: sperm cells were processed by DGC, washed and frozen in the presence of 50 mM of hypotaurine. After thawing, measurements were performed on (A) the levels of cryo-capacitation (n = 15), and (B) the percentage of altered or reacted (AR) spermatozoa (n = 25). Cryo-capacitation levels were evaluated by measuring the tyrosine phosphorylation of proteins P110 and P80 after thawing under capacitation conditions (37 °C and 5% CO2). Conditions H+ and H- were compared using parametric or non-parametric tests based on statistical distribution and number of subjects (n).** indicates significant difference with p < 0.01 in comparison to the H- condition

Sperm nuclear protection

With regard to sperm nuclear quality, chromatin packaging was significantly higher in the H+ arm than in the H- arm, from use of CMA3 labelling (− 16.0% spermatozoa with decondensed chromatin, ES = − 0.30 [− 0.57; − 0.03], p < 0.05, Fig. 3A). Sperm chromatin decondensation was significantly was reduced by hypotaurine supplementation in abnormal samples (− 20.8% p < 0.05) but not in normal ones (10.7 ± 1.0 for H- vs. 9.6 ± 1.5% for H+). Similar effects were observed with the percentages of spermatozoa with DNA fragmentation (− 18.7 ± 2.0% relative to the “H-” arm, ES = − 0.37 [− 0.80; − 0.02] p < 0.05, Fig. 3B) and nuclear vacuolization (− 20.8%, ES = − 0.34 [− 0.68; − 0.03], p < 0.05, Fig. 3C). The nuclear alterations of the spermatozoa were correlated with each other and with the different parameters measured (heatmap, Fig. 4). The percentage of CMA3+ spermatozoa was negatively correlated with the percentage of spermatozoa with nuclear vacuoles (r = − 0.4, p < 0.01), vitality (r = − 0.4, p < 0.01) and total motility (r = − 0.4, p < 0.01). The percentage of spermatozoa with fragmented DNA was negatively correlated with vitality (r = − 0.5, p < 0.01) and progressive motility (r = − 0.4, p < 0.05). The percentage of spermatozoa with nuclear vacuolization was positively correlated with the percentage of acrosome reacted spermatozoa (r = 0.4, p < 0.05).

Fig. 3
figure3

Effects of hypotaurine supplementation on sperm nuclear quality after thawing. Values are mean ± SEM for the percentage (%) of spermatozoa with (A) decondensed chromatin, (B) fragmented DNA or (C) head vacuoles.”H -”: sperm cells were processed by density gradient centrifugation (DGC), washed and frozen without hypotaurine supplementation. “H +”: sperm cells were processed by DGC, washed and frozen in the presence of 50 mM hypotaurine. The following were measured after thawing: (A) Chromatin packaging: percentage of spermatozoa with decondensed chromatin evaluated by chromomycine A3 (% CMA3 + spermatozoa, n = 28); (B) DNA fragmentation estimated by the TUNEL assay (% TUNEL + spermatozoa, n = 19). (C) nuclear vacuolization estimated by MSOME (% spermatozoa with head vacuoles, n = 19). Conditions H+ and H- were compared using parametric or non-parametric tests according to statistical distribution and the number of subjects (n).* indicates a significant difference with p < 0.05 in comparison to the H- condition

Fig. 4
figure4

Correlations between post thaw spermatozoa parameters. Heat map showing the positive (blue) and negative (red) correlations between the different parameters using Spearman correlations. *indicates a significant correlation with p < 0.05

Discussion

Despite the development of new tools and approaches for sperm cryopreservation, slow freezing remains the gold standard method for preserving male fertility [2, 3, 5]. However, sperm preparations including washing, DGC selection, as well as cryopreservation itself, are known to increase oxidative stress, leading to the alteration of the sperm membrane, its nucleus and the DNA it contains [9, 35]. In addition, DGC, removing the protective AO activities of the seminal fluid may increase the susceptibility of spermatozoa to oxidative damage [19]. In this context, the addition of AO during DGC and cryopreservation processes could have a beneficial effect on sperm structures and functions. Our previous study [28] reported a decrease in the percentage of spermatozoa with apoptotic markers when sperm selection was performed before freezing with the addition of hypotaurine. The present study clearly demonstrated the benefits of the combination of DGC and hypotaurine supplementation on spermatozoa vitality, total and progressive motility, cryo-capacitation and DNA integrity after thawing in patients with normal or abnormal conventional sperm parameters. In particular, this protocol led to a significant reduction of the proportion of spermatozoa with nuclear alterations such as chromatin decondensation, DNA fragmentation, and nuclear vacuolization.

In addition to its well-known osmoregulatory action, hypotaurine has been described as an antioxidant [36, 37]. Both hypotaurine and taurine, its immediate downstream metabolite, are naturally present in male and female human reproductive tissue. Both substances have long been reported to be related to male fertility [37,38,39]. They have been shown to play a role in various processes, including protective effects on motility [37, 40,41,42]. As the freezing medium already contains taurine in its original composition, only hypotaurine was added in the different media. Hypotaurine supplementation in the media has already shown beneficial effects on sperm function using animal models including ram, dog, golden hamster, rabbit, chicken and bull. It has improved the integrity of sperm plasma and acrosomal membranes [41, 43], reducing sperm lipid peroxidation [38, 42]. In addition, hypotaurine supplementation has been reported to decrease OS [36] and DNA fragmentation [41, 42] particularly in the context of cryopreservation [41, 42, 44, 45]. Finally, hypotaurine has been reported to improve to ability of spermatozoa to undergo capacitation, the acrosome reaction and fertilization [37, 45,46,47]. Therefore, we hypothesized that because of its combined antioxidant, anti-capacitant and osmoregulatory actions, hypotaurine supplementation of the DGC, washing and freezing media may be an appropriate choice for improving the quality of cryopreserved human spermatozoa [2, 7, 28]. A recent study has published results consistent with ours, showing the beneficial effects of hypotaurine supplementation during the vitrification of human spermatozoa, including improved acrosomal integrity, motility, morphology and reduced lipid peroxidation [48].

All measured nuclear alterations were significantly reduced by hypotaurine supplementation. The protective effects of hypotaurine on sperm nuclear integrity reported here confirmed our preliminary report [28] and are consistent with other reports that have shown that AO supplementation in freezing media protects sperm cells from DNA damage [2, 5, 23]. Our study demonstrates that the addition of AO to the selection and freezing media reduces both sperm nuclear vacuolization and alterations in chromatin packaging. In addition, we showed in the present study that sperm nuclear vacuolization was positively correlated with alterations in acrosomal integrity, but negatively with chromatin decondensation.

Hypotaurine reduced the non-specific phosphorylation of two capacitation markers induced by cryopreservation in the process known as cryo-capacitation, but had no significant impact on the integrity of the acrosome. Hypotaurine supplementation has been reported [41] in the ram model to reduce the deleterious effects of cryopreservation on the acrosome. However, Partyka et al. showed no effect on the acrosome integrity of chicken spermatozoa [42]. The action of hypotaurine appears to be dose-dependent and possibly species-specific. The 50 mM concentration was chosen on the basis of concentrations measured in the seminal and epididymal fluids of fertile men [37]. This concentration was also the highest used in this context compared to other studies [41, 42]. Our objective was to stay in a physiological concentration in order to avoid deleterious effect of antioxidant excess. It has been shown that unsuitable or excessive antioxidant supplementation can have harmful effects, in particular on chromatin condensation [49]. Our strategy could explain, at least in part, that the beneficial effect of hypotaurine was more marked for abnormal sperm for vitality and motility. Studies showed that semen from infertile men with oligoasthenoteratozoospermia contained lower hypotaurine concentration [37, 50] and that spermatozoa from these patients could be less protected against cryopreservation-induced OS [28]. Dose-response experiments will be conducted to determine which concentrations could possibly further enhance the effects of hypotaurine on human spermatozoa. In addition, hypotaurine could not be efficient to counteract all oxidative damages notably those mediated by H2O2. Indeed, publications showed that hypotaurine can scavenge the aggressive hydroxyl radical [36, 51], but its ability to deal with H2O2 (or/and H2O2-mediated damage) is not clearly established. It has recently been shown that different antioxidants, when combined, can have additive positive effects on spermatozoa (for recent reviews [2, 5, 22, 23]). Other AO will be tested in combination with hypotaurine to measure potential synergistic and/or complementary action. Numerous AO had been already tested in combination with hypotaurine such as glutathione [51], taurine [44, 45, 48] and L-carnitine [42]. The most current and efficient combination was with taurine, that was already present in the cryopreservative medium used. It is probable that the effects observed were the consequence of the combination of taurine and hypotaurine. Others AO could be envisaged [23, 52] such as selenium, zinc, vitamins C and E and also curcumin [53] for which beneficial effects have recently been shown during human sperm cryopreservation.

Conclusion

We have shown here that human sperm samples selected by DGC and frozen in the presence of hypotaurine had, post-thawing, a significantly higher proportion of live and progressively motile spermatozoa, compared to semen that were selected solely by DGC before freezing. Hypotaurine supplementation limited cryo-capacitation and reduced the percentage of spermatozoa showing chromatin decondensation, DNA fragmentation and nuclear vacuolation. Sperm cryopreservation is a valuable clinical tool for the management of male preservation fertility. Recently, the Cochrane review [52] concluded that there is poor evidence of the beneficial effects of oral antioxidant supplementation for subfertile men. We show here that hypotaurine supplementation could be easily and routinely added to improve the sperm freezing protocols.

Availability of data and materials

The datasets during and/or analysed during the current study available from the corresponding author on reasonable request.

Abbreviations

AO:

antioxidant

AR:

acrosome reacted

BMI:

body mass index

BSA:

bovin serum albumin

C.I.:

confidence interval

CMA3:

chromomycin A3

CPP:

Committee for Personal Protection

°C:

degree Celsius

DGC:

density gradient centrifugation

DNA:

deoxyribonucleic acid

FCM:

flow cytometry

Fig:

Figure

FITC:

fluorescein isothiocyanate

FSC:

forward-scattered light

h:

hour

IRB:

Institutional Review Board

OAT:

oligo-astheno-teratozoospermia

MSOME:

motile sperm organelle morphology examination

min:

minute

OS:

oxidative stress

%:

percent

PBS:

phosphate buffered saline

PMN:

PolyMorphonuclear Neutrophil

PI:

Propidium Iodide

PSA:

P. sativum agglutinin

P-Tyr:

tyrosine phosphorylation

ROS:

reactive oxygen species

RT:

room temperature

SSC:

side-scattered light

SEM:

Standard Error of the Mean

Spz:

spermatozoa

WHO:

World Health Organization

References

  1. 1.

    Di Santo M, Tarozzi N, Nadalini M, Borini A. Human sperm cryopreservation: update on techniques, effect on DNA integrity, and implications for ART. Adv Urol. 2012;2012:854837.

    PubMed  Article  PubMed Central  Google Scholar 

  2. 2.

    Hezavehei M, Sharafi M, Kouchesfahani HM, Henkel R, Agarwal A, Esmaeili V, et al. Sperm cryopreservation: a review on current molecular cryobiology and advanced approaches. Reprod BioMed Online. 2018;37(3):327–39.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  3. 3.

    Li Y-X, Zhou L, Lv M-Q, Ge P, Liu Y-C, Zhou D-X. Vitrification and conventional freezing methods in sperm cryopreservation: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2019;233:84–92.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  4. 4.

    Kopeika J, Thornhill A, Khalaf Y. The effect of cryopreservation on the genome of gametes and embryos: principles of cryobiology and critical appraisal of the evidence. Hum Reprod Update. 2015;21(2):209–27.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  5. 5.

    Sharma R, Kattoor AJ, Ghulmiyyah J, Agarwal A. Effect of sperm storage and selection techniques on sperm parameters. Syst Biol Reprod Med. 2015;61(1):1–12.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  6. 6.

    Gómez-Torres MJ, Medrano L, Romero A, Fernández-Colom PJ, Aizpurúa J. Effectiveness of human spermatozoa biomarkers as indicators of structural damage during cryopreservation. Cryobiology. 2017;78:90–4.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  7. 7.

    Pini T, Leahy T, de Graaf SP. Sublethal sperm freezing damage: manifestations and solutions. Theriogenology. 2018;118:172–81.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  8. 8.

    Aitken RJ, Baker MA. Oxidative stress, sperm survival and fertility control. Mol Cell Endocrinol. 2006;250(1–2):66–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  9. 9.

    Tremellen K. Oxidative stress and male infertility--a clinical perspective. Hum Reprod Update. 2008;14(3):243–58.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  10. 10.

    Aitken RJ, De Iuliis GN, Finnie JM, Hedges A, McLachlan RI. Analysis of the relationships between oxidative stress, DNA damage and sperm vitality in a patient population: development of diagnostic criteria. Hum Reprod. 2010;25(10):2415–26.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  11. 11.

    Oehninger S, Duru NK, Srisombut C, Morshedi M. Assessment of sperm cryodamage and strategies to improve outcome. Mol Cell Endocrinol. 2000;169(1–2):3–10.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  12. 12.

    Lewis SEM, John Aitken R, Conner SJ, Iuliis GD, Evenson DP, Henkel R, et al. The impact of sperm DNA damage in assisted conception and beyond: recent advances in diagnosis and treatment. Reprod BioMed Online. 2013;27(4):325–37.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  13. 13.

    Thomson LK, Fleming SD, Aitken RJ, De Iuliis GN, Zieschang J-A, Clark AM. Cryopreservation-induced human sperm DNA damage is predominantly mediated by oxidative stress rather than apoptosis. Hum Reprod. 2009;24(9):2061–70.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  14. 14.

    Aitken RJ, De Iuliis GN. On the possible origins of DNA damage in human spermatozoa. Mol Hum Reprod. 2010;16(1):3–13.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  15. 15.

    Medeiros CMO, Forell F, Oliveira ATD, Rodrigues JL. Current status of sperm cryopreservation: why isn’t it better? Theriogenology. 2002;57(1):327–44.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  16. 16.

    Pons-Rejraji H, Bailey JL, Leclerc P. Cryopreservation affects bovine sperm intracellular parameters associated with capacitation and acrosome exocytosis. Reprod Fertil Dev. 2009;21(4):525–37.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  17. 17.

    Naresh S, Atreja SK. The protein tyrosine phosphorylation during in vitro capacitation and cryopreservation of mammalian spermatozoa. Cryobiology. 2015;70(3):211–6.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Petyim S, Neungton C, Thanaboonyawat I, Laokirkkiat P, Choavaratana R. Sperm preparation before freezing improves sperm motility and reduces apoptosis in post-freezing-thawing sperm compared with post-thawing sperm preparation. J Assist Reprod Genet. 2014;31(12):1673–80.

    PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Grizard G, Chevalier V, Griveau JF, Le Lannou D, Boucher D. Influence of seminal plasma on cryopreservation of human spermatozoa in a biological material-free medium: study of normal and low-quality semen. Int J Androl. 1999;22(3):190–6.

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Palomar Rios A, Gascón A, Martínez JV, Balasch S, Molina BI. Sperm preparation after freezing improves motile sperm count, motility, and viability in frozen-thawed sperm compared with sperm preparation before freezing-thawing process. J Assist Reprod Genet. 2018;35(2):237–45.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  21. 21.

    Aghaz F, Khazaei M, Vaisi-Raygani A, Bakhtiyari M. Cryoprotective effect of sericin supplementation in freezing and thawing media on the outcome of cryopreservation in human sperm. Aging Male. 2018;19:1–8.

    Google Scholar 

  22. 22.

    Amidi F, Pazhohan A, Shabani Nashtaei M, Khodarahmian M, Nekoonam S. The role of antioxidants in sperm freezing: a review. Cell Tissue Bank. 2016;17(4):745–56.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  23. 23.

    Bahmyari R, Zare M, Sharma R, Agarwal A, Halvaei I. The efficacy of antioxidants in sperm parameters and production of reactive oxygen species levels during the freeze-thaw process: a systematic review and meta-analysis. Andrologia. 2020;52(3):e13514.

    PubMed  Article  PubMed Central  Google Scholar 

  24. 24.

    Ghorbani M, Vatannejad A, Khodadadi I, Amiri I, Tavilani H. Protective effects of glutathione supplementation against oxidative stress during cryopreservation of human spermatozoa. Cryo Letters. 2016;37(1):34–40.

    PubMed  PubMed Central  Google Scholar 

  25. 25.

    Hatef B, Taromchi A, Nejatbakhsh R, Farrokhi A, Shokri S. Supplementation of freezing media with stromal cell-derived factor-1α preserves human sperm from cryodamage. Cryobiology. 2017;79:37–42.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  26. 26.

    Liu J, Wang W, Liu X, Wang X, Wang J, Wang Y, et al. Supplementation of cryopreservation medium with TAT-Peroxiredoxin 2 fusion protein improves human sperm quality and function. Fertil Steril. 2018;110(6):1058–66.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  27. 27.

    Zhang W, Li F, Cao H, Li C, Du C, Yao L, et al. Protective effects of l-carnitine on astheno- and normozoospermic human semen samples during cryopreservation. Zygote. 2016;24(2):293–300.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  28. 28.

    Brugnon F, Ouchchane L, Pons-Rejraji H, Artonne C, Farigoule M, Janny L. Density gradient centrifugation prior to cryopreservation and hypotaurine supplementation improve post-thaw quality of sperm from infertile men with oligoasthenoteratozoospermia. Hum Reprod. 2013;28(8):2045–57.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  29. 29.

    Aliabadi E, Jahanshahi S, Talaei-Khozani T, Banaei M. Comparison and evaluation of capacitation and acrosomal reaction in freeze-thawed human ejaculated spermatozoa treated with L-carnitine and pentoxifylline. Andrologia. 2018;50(2). https://doi.org/10.1111/and.12845.

  30. 30.

    WHO | WHO laboratory manual for the examination and processing of human semen [Internet]. WHO. [cited 2015 Jul 28]. Available from: http://www.who.int/reproductivehealth/publications/infertility/9789241547789/en/

  31. 31.

    Menkveld R, Stander FS, Kotze TJ, Kruger TF, van Zyl JA. The evaluation of morphological characteristics of human spermatozoa according to stricter criteria. Hum Reprod. 1990;5(5):586–92.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  32. 32.

    Pons-Rejraji H, Artonne C, Sion B, Brugnon F, Canis M, Janny L, et al. Prostasomes: inhibitors of capacitation and modulators of cellular signalling in human sperm. Int J Androl. 2011;34(6 Pt 1):568–80.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  33. 33.

    Pons-Rejraji H, Brugnon F, Sion B, Maqdasy S, Gouby G, Pereira B, et al. Evaluation of atorvastatin efficacy and toxicity on spermatozoa, accessory glands and gonadal hormones of healthy men: a pilot prospective clinical trial. Reprod Biol Endocrinol. 2014;12:65.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  34. 34.

    Cohen J. Statistical power analysis for the behaviors sciences (2nd ed.). NJ: Lawrence Earbaum Associates.

  35. 35.

    Zribi N, Feki Chakroun N, El Euch H, Gargouri J, Bahloul A, Ammar KL. Effects of cryopreservation on human sperm deoxyribonucleic acid integrity. Fertil Steril. 2010;93(1):159–66.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  36. 36.

    Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J. 1988;256(1):251–5.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Holmes RP, Goodman HO, Shihabi ZK, Jarow JP. The taurine and hypotaurine content of human semen. J Androl. 1992;13(3):289–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Alvarez JG, Storey BT. Taurine, hypotaurine, epinephrine and albumin inhibit lipid peroxidation in rabbit spermatozoa and protect against loss of motility. Biol Reprod. 1983;29(3):548–55.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  39. 39.

    Guérin P, Guillaud J, Ménézo Y. Hypotaurine in spermatozoa and genital secretions and its production by oviduct epithelial cells in vitro. Hum Reprod. 1995;10(4):866–72.

    PubMed  Article  Google Scholar 

  40. 40.

    Boatman DE, Bavister BD, Cruz E. Addition of hypotaurine can reactivate immotile golden hamster spermatozoa. J Androl. 1990;11(1):66–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Bucak MN, Keskin N, Taşpınar M, Çoyan K, Başpınar N, Cenariu MC, et al. Raffinose and hypotaurine improve the post-thawed merino ram sperm parameters. Cryobiology. 2013;67(1):34–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  42. 42.

    Partyka A, Rodak O, Bajzert J, Kochan J, Niżański W. The effect of L-Carnitine, Hypotaurine, and Taurine supplementation on the quality of cryopreserved chicken semen. Biomed Res Int. 2017;2017:7279341.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  43. 43.

    Asano A, Roman HB, Hirschberger LL, Ushiyama A, Nelson JL, Hinchman MM, et al. Cysteine dioxygenase is essential for mouse sperm osmoadaptation and male fertility. FEBS J. 2018;285(10):1827–39.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  44. 44.

    Chen Y, Foote RH, Brockett CC. Effect of sucrose, trehalose, hypotaurine, taurine, and blood serum on survival of frozen bull sperm. Cryobiology. 1993;30(4):423–31.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  45. 45.

    Martins-Bessa A, Rocha A, Mayenco-Aguirre A. Effects of taurine and hypotaurine supplementation and ionophore concentrations on post-thaw acrosome reaction of dog spermatozoa. Theriogenology. 2009;71(2):248–53.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  46. 46.

    Meizel S. Molecules that initiate or help stimulate the acrosome reaction by their interaction with the mammalian sperm surface. Am J Anat. 1985;174(3):285–302.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  47. 47.

    Buff S, Donzé A, Guérin P, Guillaud J, Fontbonne A, Ménézo Y. Taurine and hypotaurine in spermatozoa and epididymal fluid of cats. J Reprod Fertil Suppl. 2001;57:93–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. 48.

    Seify M, Zarabadipour M, Ghaleno LR, Alizadeh A, Rezazadeh VM. The anti-oxidant roles of Taurine and Hypotaurine on acrosome integrity, HBA and HSPA2 of the human sperm during vitrification and post warming in two different temperature. Cryobiology. 2019;19.89–95. https://doi.org/10.1016/j.cryobiol.2019.07.004. PMID: 31330124.

  49. 49.

    Ménézo YJR, Hazout A, Panteix G, Robert F, Rollet J, Cohen-Bacrie P, et al. Antioxidants to reduce sperm DNA fragmentation: an unexpected adverse effect. Reprod BioMed Online. 2007;14(4):418–21.

    PubMed  Article  PubMed Central  Google Scholar 

  50. 50.

    Holmes RP, Goodman HO, Hurst CH, Shihabi ZK, Jarow JP. Hypotaurine in male reproduction. Adv Exp Med Biol. 1992;315:437–41.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  51. 51.

    Donnelly ET, McClure N, Lewis SE. Glutathione and hypotaurine in vitro: effects on human sperm motility, DNA integrity and production of reactive oxygen species. Mutagenesis. 2000;15(1):61–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  52. 52.

    Smits RM, Mackenzie-Proctor R, Yazdani A, Stankiewicz MT, Jordan V, Showell MG. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2019 14;3:CD007411.

  53. 53.

    Santonastaso M, Mottola F, Iovine C, Colacurci N, Rocco L. Protective Effects of Curcumin on the Outcome of Cryopreservation in Human Sperm. Reprod Sci. 2021; https://doi.org/10.1007/s43032-021-00572-9.

Download references

Acknowledgements

The authors would like to thank Lambert Celine for its biostastical assistance during the course of the study.

Funding

This work was funded by institutional grants from the Université Clermont Auvergne and by a hospital grant from the Hospital Clinical Research Program of the French Ministry of Health [PHRC “Congélation des spermatozoïdes et MSOME”, PI_AOI 2011].

Author information

Affiliations

Authors

Contributions

Hanae Pons-Rejraji: HP; Solène Vorilhon: SV; Asmaa Difrane: AD; Sandra Dollet: SD; Céline Bourgne: CB; Marc Berger: MB; Laure. Chaput: LC; Bruno Pereira: BP; Cyril Bouche CB1: Joel R. Drevet: JRD; Florence. Brugnon: FB. HP and FB designed the study, conducted the research and wrote the article. BP performed the statistical analyses and interpretations and contributed to manuscript revision in collaboration with HP and SV. SV, SD, AD, CB1, LC and HP performed the semen analyses. CB and MB contributed to carrying out the FCM analysis and interpretations. JRD contributed to the manuscript revision. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Hanae Pons-Rejraji.

Ethics declarations

Ethics approval and consent to participate

Written informed consent was obtained from each patient before freezing semen samples in the “Germethèque” biobank. This study was approved by the Germetheque Scientific Committee and the Ethics Committee under the French IRB reference CPP Sud-Est 6, DC2008-DC58, Clinical number: NCT04011813.

Consent for publication

Not applicable.

Competing interests

JRD is scientific advisor of a US-based biotech company (Celloxess, Princeton, NJ, USA) involved in preventive medicine with a focus on the generation of antioxidant oral supplements.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pons-Rejraji, H., Vorilhon, S., Difrane, A. et al. Beneficial effects of hypotaurine supplementation in preparation and freezing media on human sperm cryo-capacitation and DNA quality. Basic Clin. Androl. 31, 26 (2021). https://doi.org/10.1186/s12610-021-00144-6

Download citation

Keywords

  • Cryopreservation
  • Human spermatozoa
  • Density gradient centrifugation
  • DNA fragmentation and oxidation
  • Chromatin packaging
  • Acrosome
  • Capacitation and cryocapacitation

Mots clés

  • cryoconservation
  • spermatozoïdes humains
  • test de migration survie
  • fragmentation et oxydation de l’ADN
  • condensation de la chromatine
  • réaction acrosomique
  • capacitation et cryocapacitation